US set to vaccinate adolescents to allow in-person learning in schools
Washington: The US is set to vaccinate low-risk teens even as the deadly coronavirus pandemic is raging globally.
Reports said authorization of the Pfizer Covid-19 vaccine in adolescents is likely to help the United States to allow more schools to return to in-person learning.
The decision has, however, sparked a debate about the ethical considerations of vaccinating a low-risk population.
The Pfizer and its partner BioNTech said in March their two-dose regimen was shown to be safe and highly effective in a trial of nearly 2,300 12 to 15 year-olds.
Many experts have, however, voiced concern whether this is the right time to immunize American teens as the global situation deteriorates.
In the US under-18s have accounted for 277 deaths in total, according to the latest official data. This is a miniscule fraction of the total of 574,000.